Patel A - Search Results

1

Silver nanoparticles: synthesis, properties, and therapeutic applications.

Wei L, Lu J, Xu H, Patel A, Chen ZS, Chen G. Wei L, et al. Among authors: patel a. Drug Discov Today. 2015 May;20(5):595-601. doi: 10.1016/j.drudis.2014.11.014. Epub 2014 Dec 24. Drug Discov Today. 2015. PMID: 25543008 Free PMC article. Review.

2

Role of ABC transporters in cancer chemotherapy.

Sun YL, Patel A, Kumar P, Chen ZS. Sun YL, et al. Among authors: patel a. Chin J Cancer. 2012 Feb;31(2):51-7. doi: 10.5732/cjc.011.10466. Epub 2012 Jan 17. Chin J Cancer. 2012. PMID: 22257384 Free PMC article.

3

Multidrug resistance associated proteins in multidrug resistance.

Sodani K, Patel A, Kathawala RJ, Chen ZS. Sodani K, et al. Among authors: patel a. Chin J Cancer. 2012 Feb;31(2):58-72. doi: 10.5732/cjc.011.10329. Epub 2011 Nov 18. Chin J Cancer. 2012. PMID: 22098952 Free PMC article. Review.

4

Tyrosine kinase inhibitors as reversal agents for ABC transporter mediated drug resistance.

Anreddy N, Gupta P, Kathawala RJ, Patel A, Wurpel JN, Chen ZS. Anreddy N, et al. Among authors: patel a. Molecules. 2014 Sep 4;19(9):13848-77. doi: 10.3390/molecules190913848. Molecules. 2014. PMID: 25191874 Free PMC article. Review.

5

Roles of sildenafil in enhancing drug sensitivity in cancer.

Shi Z, Tiwari AK, Patel AS, Fu LW, Chen ZS. Shi Z, et al. Cancer Res. 2011 Jun 1;71(11):3735-8. doi: 10.1158/0008-5472.CAN-11-0375. Epub 2011 May 24. Cancer Res. 2011. PMID: 21610107 Free PMC article. Review.

6

GW583340 and GW2974, human EGFR and HER-2 inhibitors, reverse ABCG2- and ABCB1-mediated drug resistance.

Sodani K, Tiwari AK, Singh S, Patel A, Xiao ZJ, Chen JJ, Sun YL, Talele TT, Chen ZS. Sodani K, et al. Among authors: patel a. Biochem Pharmacol. 2012 Jun 15;83(12):1613-22. doi: 10.1016/j.bcp.2012.02.028. Epub 2012 Mar 7. Biochem Pharmacol. 2012. PMID: 22414725 Free PMC article.

7

OSI-930 analogues as novel reversal agents for ABCG2-mediated multidrug resistance.

Kuang YH, Patel JP, Sodani K, Wu CP, Liao LQ, Patel A, Tiwari AK, Dai CL, Chen X, Fu LW, Ambudkar SV, Korlipara VL, Chen ZS. Kuang YH, et al. Among authors: patel a, patel jp. Biochem Pharmacol. 2012 Sep 15;84(6):766-74. doi: 10.1016/j.bcp.2012.06.019. Epub 2012 Jun 28. Biochem Pharmacol. 2012. PMID: 22750060 Free PMC article.

8

Nilotinib potentiates anticancer drug sensitivity in murine ABCB1-, ABCG2-, and ABCC10-multidrug resistance xenograft models.

Tiwari AK, Sodani K, Dai CL, Abuznait AH, Singh S, Xiao ZJ, Patel A, Talele TT, Fu L, Kaddoumi A, Gallo JM, Chen ZS. Tiwari AK, et al. Among authors: patel a. Cancer Lett. 2013 Jan 28;328(2):307-17. doi: 10.1016/j.canlet.2012.10.001. Epub 2012 Oct 9. Cancer Lett. 2013. PMID: 23063650 Free PMC article.

9

PD173074, a selective FGFR inhibitor, reverses ABCB1-mediated drug resistance in cancer cells.

Patel A, Tiwari AK, Chufan EE, Sodani K, Anreddy N, Singh S, Ambudkar SV, Stephani R, Chen ZS. Patel A, et al. Cancer Chemother Pharmacol. 2013 Jul;72(1):189-99. doi: 10.1007/s00280-013-2184-z. Epub 2013 May 15. Cancer Chemother Pharmacol. 2013. PMID: 23673445 Free PMC article.

10

bba, a synthetic derivative of 23-hydroxybutulinic acid, reverses multidrug resistance by inhibiting the efflux activity of MRP7 (ABCC10).

Chen JJ, Patel A, Sodani K, Xiao ZJ, Tiwari AK, Zhang DM, Li YJ, Yang DH, Ye WC, Chen SD, Chen ZS. Chen JJ, et al. Among authors: patel a. PLoS One. 2013 Sep 17;8(9):e74573. doi: 10.1371/journal.pone.0074573. eCollection 2013. PLoS One. 2013. PMID: 24069321 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14,891 results

Search Page

Filters